OrphanDrug
OrphanDrug
Pharma Knowledge Base

glucocorticoid-remediable aldosteronism

MeSH: C563177ORPHA: 403

Contents

  1. 1. Overview
  2. 2. Available Treatments
  3. 3. Clinical Presentation
  4. 4. Classification & Codes

Overview

Human disease

Available Treatments (0)

No treatments linked yet

Clinical trials or compassionate use may be available — consult a specialist.

Clinical Presentation

Signs and symptoms associated with glucocorticoid-remediable aldosteronism, sourced from HPO and Orphanet clinical annotations.

HypertensionDexamethasone-suppressible primary hyperaldosteronismAdrenal hyperplasiaAbnormal circulating renin concentrationTinnitusEpistaxisMuscle weaknessPolydipsiaNauseaIntracranial hemorrhageHeadacheHypokalemiaCaesarean sectionSecretory adrenocortical adenoma

Classification & Codes

MeSH Code

C563177

Orphanet Code

ORPHA:403
glucocorticoid-remediable aldosteronism
MeSHC563177
OrphanetORPHA:403
Treatments0 drug(s)
Symptoms on record14 signs
Statuspublished
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO